Search Results

BDMDW Baird Medical Investment Holdings Limited - Fundamental Analysis

BEARISH
Sign in to save Save this symbol to a watchlist or track a position.
BDMDW Stock | Fundamental Analysis & Investment Insights
NASDAQ N/A N/A
Current Price Live
$0.05
52W High
$0.06
52W Low
$0.05
Overview AI Snowflake Price Valuation Profitability Growth Health

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
N/A
P/E
N/A
ROE
-8.0%
Profit margin
-10.0%
Debt/Equity
0.63
Dividend yield
N/A

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
85%
Analysis Accuracy
The company exhibits weak fundamental health with a Piotroski F-Score of 3/9, indicating poor financial strength. Despite a seemingly strong gross margin of 86.94%, the firm is unprofitable with negative operating and net margins, declining revenue, and no meaningful valuation metrics due to lack of earnings and cash flow data. The absence of an Altman Z-Score and Graham Number, combined with stagnant price performance and no analyst coverage, suggests high uncertainty and elevated risk. Overall, the deterministic models signal distress, and there is insufficient evidence to support a bullish outlook.

Key Strengths

High gross margin (86.94%) suggests strong pricing power or low cost of goods sold
Current ratio of 1.71 indicates short-term liquidity is adequate
Quick ratio of 1.22 shows ability to meet short-term obligations without inventory
Debt/Equity of 0.63 is moderate and not excessively leveraged
Price stable near 52-week range, showing no recent panic selling

Key Risks

Piotroski F-Score of 3/9 signals weak financial health and high risk of underperformance
Operating margin of -131.30% indicates severe operational inefficiency or unsustainable costs
Revenue down 39.40% year-over-year, reflecting significant business contraction
No Altman Z-Score available, increasing uncertainty about bankruptcy risk
Lack of market cap, enterprise value, cash, debt, and cash flow data suggests poor transparency or reporting issues

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
22
Weak
Value
30
Future
20
Past
35
Health
25
Dividend
0
AI Verdict
High risk, low quality, unattractive investment
Key drivers: Low Piotroski F-Score, Negative profitability metrics, Revenue decline, Missing valuation and cash flow data, No analyst coverage
Confidence
88%
Value
30/100

Ref P/E, PEG, Graham Number

Positives
  • Price/Book ratio of 0.04 may appear deeply undervalued
Watchpoints
  • P/E and Forward P/E are N/A due to lack of earnings
  • No Graham Number or intrinsic value available
  • Low P/B could reflect asset erosion or accounting issues
Future
20/100

Ref Growth rates

Positives
No standout positives identified.
Watchpoints
  • Revenue Growth (YoY): -39.40%
  • No earnings growth data available
  • No analyst target prices or growth estimates
Past
35/100

Ref Historical trends

Positives
  • 52-week price range stable between $0.05 and $0.06
Watchpoints
  • 5Y, 3Y, 1Y price changes all at 0.0%, indicating stagnation
  • No historical trend improvement despite time
Health
25/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Current and quick ratios above 1.0 suggest short-term solvency
Watchpoints
  • Piotroski F-Score of 3/9 indicates weak financial health
  • ROE of -8.03% and ROA of -0.20% show poor returns
  • Operating margin of -131.30% is critically weak
  • No Altman Z-Score available for distress assessment
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend Strength: 0/100
  • No dividend yield, rate, or payout data available
  • No history of dividend payments

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.05

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BDMDW and closest competitors.

Updated 2026-01-23
Company 5Y 3Y 1Y 6M 1M 1W
BDMDW
Baird Medical Investment Holdings Limited
Primary
 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
0.04
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin -9.95%
Operating Margin -131.3%
Gross Margin 86.94%
ROE -8.03%
ROA -0.2%

Growth

Revenue and earnings growth rates

Revenue Growth -39.4%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.63
Moderate
Current Ratio
1.71
Good
Quick Ratio
1.22
Good
Cash/Share
$0.09

Past News Coverage

Recent headlines mentioning BDMDW from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Intelligence Terminal AI Assistant Trading Challenge Analysis Market News Pricing
Sign In Get Started
Home
Terminal
AI
Markets
Profile